Bundamedik Tbk vs Prodia Widyahusada Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Prodia Widyahusada Tbk. trades at Rp2,400 (market cap 2.23T, 351K 24h volume). The key difference: Prodia Widyahusada Tbk. is the larger of the two by market cap, and Bundamedik Tbk is more actively traded (536.7K versus 351K). Which is the better fit depends on your goals.
| BMHS | PRDA | |
|---|---|---|
Market Cap | 1.51T | 2.23T |
Volume | 536.7K | 351K |
Lot | 5.37K | 3.51K |
Turnover | 93.41M | 842.03M |
Average Price | 174.05 | 2,398.95 |
Value | 93.41M | 842.03M |
Indicative Equilibrium Price | 176 | 2,400 |
Indicative Equilibrium Volume | 100 | 65 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT Prodia Widyahusada Tbk (the Company) was established based on the Deed of Notary Sri Rahayu, SH, No. 14 dated February 8, 1988. Clinical Laboratory Prodia was first established in Solo, Central Java, on May 7, 1973 by a few idealists pharmaceutical educational background.
Read more on PRDA →